6059-29-6 Usage
Description
[3-[(Benzyl)oxy]-2-pyridinyl]methanol is a chemical compound belonging to the alcohol family, characterized by its molecular formula C16H15NO2. It features a benzyl group, a pyridine ring, and a hydroxyl functional group, making it a versatile building block in organic synthesis.
Uses
Used in Pharmaceutical Industry:
[3-[(Benzyl)oxy]-2-pyridinyl]methanol is used as a key intermediate in the synthesis of various pharmaceuticals due to its unique structural features, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
[3-[(Benzyl)oxy]-2-pyridinyl]methanol is also utilized as a building block in the production of agrochemicals, playing a crucial role in the synthesis of effective pesticides and other agricultural chemicals to enhance crop protection and yield.
Used in Medicinal Chemistry:
[3-[(Benzyl)oxy]-2-pyridinyl]methanol serves as a valuable component in medicinal chemistry, where its structural attributes can be exploited to design and develop novel molecules with potential therapeutic properties.
Used in Drug Development:
Its potential applications in drug development are attributed to the compound's structural features, which can be harnessed to create new drug candidates with improved pharmacological profiles.
Safety Note:
It is essential to handle [3-[(Benzyl)oxy]-2-pyridinyl]methanol with care and adhere to proper safety protocols when working with it in a laboratory setting to ensure the safety of researchers and the integrity of experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 6059-29-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,5 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6059-29:
(6*6)+(5*0)+(4*5)+(3*9)+(2*2)+(1*9)=96
96 % 10 = 6
So 6059-29-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO2/c15-9-12-13(7-4-8-14-12)16-10-11-5-2-1-3-6-11/h1-8,15H,9-10H2
6059-29-6Relevant articles and documents
Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation
Wang, Junfeng,Wang, Huan,Ramsay, Ian A.,Erstad, Derek J.,Fuchs, Bryan C.,Tanabe, Kenneth K.,Caravan, Peter,Gale, Eric M.
, p. 8811 - 8824 (2018/10/09)
Gd-based MRI contrast agents (GBCAs) have come under intense regulatory scrutiny due to concerns of Gd retention and delayed toxicity. Three GBCAs comprising acyclic Gd chelates, the class of GBCA most prone to Gd release, are no longer marketed in Europe
AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE
-
Paragraph 00341, (2013/06/05)
The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter-and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Stereoselective synthesis of swainsonines from pyridines
Heimg?rtner, Gerres,Raatz, Dirk,Reiser, Oliver
, p. 643 - 655 (2007/10/03)
An efficient synthesis of (-)-swainsonine and (-)-2,8a-di-epi-swainsonine was developed starting from readily available 2-pyridinecarbaldehyde and 3-hydroxypyridine. In particular, it was demonstrated that the mixture of simple indolizidines, i.e. lentigi
